top of page

REVIVO BioSystems in an innovative and service-oriented company specialising in 4D human tissue models. We recreate microphysiological conditions in our organ-on-chip platform technology as close as possible to the ones in the human body so that natural tissue properties are established in our ex vivo and in vitro models. We demonstrate superior morphology and barrier properties in our 4D tissue models and the ability to mimic the function of the blood flow. This next generation technology enables new discovery and methods in mechanistic studies for quantifying and qualifying the safety, efficacy and permeation of active ingredients and product formulations.

Our team of engineers and biologists has many years of experience in biomedical engineering, cell cultures, microfluidics and tissue engineering. Aiming to become the leading Asian and global provider of enabling technologies and services for ex vivo and in vitro testing of chemicals, ingredients, cosmetic formulations and therapeutics, our goal is to deliver products and services with unmatched quality, consistency, reproducibility, convenience, and ease-of-use.
 

At REVIVO Biosystems, we are still feeling tremendous excitement over the recent progress we made! I want to take this opportunity to reiterate my appreciation for your interest and support. I’d also like to share some details about our Dare to Act brand philosophy. Reflecting our corporate culture,  it drives our operations and expands the level of engagement and support we provide. 

 

Dare to Act characterizes our fearless, multidisciplinary approach to research. At REVIVO Biosystems we encourage scientists and researchers to transcend the boundaries between scientific disciplines: to explore the intersection of biology and microfluidics; to expand the relationship between bioengineering and skincare. Our engineers are at their best when the challenge is greatest. Toxicologists, chemists, and pharmacologists are truly inspired as they dare to develop new, alternative, and more ethical methodologies. These innovators dare to push the boundaries, fully aware that as science advances, so too will humanity.

 

Dare to Act is our way of validating the trust you have placed in us. It facilitates the ongoing development of strong commercial propositions and the efficient generation of reliable support data for successful mechanistic safety and efficacy claim differentiation. Going from strength to strength, we build on our knowledge and unique expertise in 4D models to understand the mode of action of ingredients and actives. With us, you have access to the most realistic human tissue models and testing platform — models that mimic blood flow to recreate the dynamic conditions of life. Ultimately, anything is possible if you Dare to Act

Dr. Massimo Alberti

CEO of REVIVO BioSystems

The Team

IMG_0644_edited.jpg
IMG_0687_edited.jpg

Dr. Bert Grobben
CBO / Co-Founder

Dr. Massimo Alberti
CEO / Founder

  • LinkedIn Transparent
  • LinkedIn Transparent
A07I4052.jpg

Dr. Sebastien Teissier
Head of Ex Vivo &
In Vitro Testing

  • LinkedIn Transparent
15-09-2022-20-08-58_edited.jpg
A07I5508.jpg
A07I9834-Edit-2.jpg

Vera Bonderovic
Marketing & Customer Development Officer

Vishwanath Magendran
Mechatronics Engineer

Dr. Gladys Teo
Head of
Business Development

  • LinkedIn Transparent
  • LinkedIn Transparent
  • LinkedIn Transparent
Manuela profile pic_small.jpeg
A07I7322_edited_edited.jpg
Amp.jpg

Joey Chew
Research Officer

Manuela Vidolova
Marketing & Customer Success Coordinator

Amp Grobben
Customer Development

  • LinkedIn Transparent
  • LinkedIn Transparent
  • LinkedIn Transparent

Advisory Board Members

IMG_0676_edited.jpg

Prof. Sriram Gopu 

Scientific Advisor / Co-Founder

  • LinkedIn Transparent
Zhiping.png

Dr. Zhiping Wang
Scientific Advisor / Co-Founder

  • LinkedIn Transparent
AdKetelaars (1).png
Screenshot%202020-12-16%20at%2011.31_edi
Chris Thoen.jpg

Dr. Alain Khaiat

Dr. Chris Thoen

Ad Ketelaars

  • LinkedIn Transparent
  • LinkedIn Transparent
  • LinkedIn Transparent
Screenshot 2021-07-21 at 7.08.02 AM.png

Jenny Chew

  • LinkedIn Transparent
Screenshot 2021-01-11 at 6.03.30 AM.png

Dr. Akira Date

  • LinkedIn Transparent

AWARD WINNING PLATFORM

Nature award 2.png
N3XT_logo_PNG_R_PurpleYellow.png
18-TA-338-IEEEEntrepreneurship_Color_RGB
Too-500-round-rec.png
Award Winning

PARTNERS

Evonik.png
ASTAR_SIMTech_Horizontal Logo_RGB copy.p
Asset 32 (1).png
5HT Digital Hub Chemistry Health_Logo.png
AFSA.webp

WHERE TO FIND US

bottom of page